Gerard LAMBEAU,Nicola M. Tomas,Barbara Seitz-Polski,Rolf A.K. Stahl
申请号：
US16106141
公开号：
US20180356417A1
申请日:
2018.08.21
申请国别(地区):
US
年份:
2018
代理人:
摘要：
An in vitro method can diagnose membranous nephropathy patient. The method includes detecting in a biological sample obtained from the patient one or more autoantibodies recognizing a Thrombospondin, Type I. Domain Containing 7A (THSD7A) protein.
